Research Bio
Dr. Halterman's laboratory studies the damage associated with global brain ischemia, with a particular focus on identifying novel therapeutic targets in transcriptional signaling networks. Using a variety of models, they study the effects of hypoxia-ischemia on both the adult nervous system as well as the progenitor cells active within the immature and adult brain. His laboratory is supported by grants from the NIH/NINDS. He also has extensive experience in the field of gene therapy and holds several patents in the areas of gene transfer, drug discovery and medical informatics.
2012 Oct
Rininger A, Dejesus C, Totten A, Wayland A, Halterman MW. "MKP-1 antagonizes C/EBP? activity and lowers the apoptotic threshold after ischemic injury." Cell death and differentiation. 2012 Oct 0; 19(10):1634-43. Epub 2012 Apr 20. |
2012 Jun 15
Rininger A, Wayland A, Prifti V, Halterman MW. "Assessment of CA1 injury after global ischemia using supervised 2D analyses of nuclear pyknosis." Journal of neuroscience methods. 2012 Jun 15; 207(2):181-8. Epub 2012 Apr 21. |
2011 Mar
Segel GB, Halterman MW, Lichtman MA. "The paradox of the neutrophil's role in tissue injury." Journal of leukocyte biology. 2011 Mar 0; 89(3):359-72. Epub 2010 Nov 19. |
2011 Mar
Halterman MW. "An improved method for the study of apoptosis-related genes using the tet-on system." Journal of biomolecular screening : the official journal of the
Society for Biomolecular Screening. 2011 Mar 0; 16(3):332-7. Epub 2011 Feb 18. |
2011
Qazi A, Halterman MW, Mi Z, Zhang T, Schor NF. "Chopper is prodeath regardless of the effect of p75ICD on sensitivity to oxidative stress." Oxidative medicine and cellular longevity. 2011 2011:391659. Epub 2011 Sep 05. |
